The FongAI Fall Prevention Skeletal Assessment App is the core product of FongAI CO., LTD., specially designed for seniors to assess mobility and fall risk. Based on the Short Physical Performance Battery (SPPB), the application collects and analyzes horizontal and vertical mobility data through tests such as balance, chair stand, and walking. After this data is analyzed by FongAI CO., LTD.'s proprietary AI model, it precisely calculates the core stability of the elderly and provides personalized health recommendations based on the results. The FongAI App also enables long-term dynamic tracking to help users and administrators more accurately grasp changes in health status, and provides exercise courses or referrals to medical institutions for further evaluation for high-risk cases. This product has been successfully implemented at multiple locations across Taiwan, providing effective fall risk management and mobility improvement solutions for over 40,000 seniors.

"Al-Screening" is an A.I. interpretation of the biomedical system developed by big data mobile technology to accelerate the labeling of cardiovascular diseases, assist doctors in obtaining cardiovascular analysis reports, and give the suggestion base on b

"AI-Screening" is an AI-powered biomedical interpretation system developed by Precision Biotech. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data-driven analytical recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation across medical institutions.

"BD-CARdio" is an ECG-AI interpretation system developed by Precision Biotech. It accelerates the generation of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data-driven analytical recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.

"AI-Screening" is an AI-powered biomedical interpretation system developed by Big Data Precision Biotechnology Corp. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data analysis recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation in medical institutions.

"BD-CARdio" is an ECG-AI interpretation system developed by Big Data Precision Biotechnology Corp. It accelerates the acquisition of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data analysis recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.